New yellow fever vaccine shows promise in japanese adults
NCT ID NCT07222059
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 29 times
Summary
This study tested a new yellow fever vaccine (vYF) in 254 healthy adults aged 18 and older in Japan. Participants received one shot, and researchers checked for safety and immune response after about a month. The goal was to see if the vaccine triggers enough protection against yellow fever virus.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for YELLOW FEVER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number : 3920001
Takatsuki, Osaka, 569-1192, Japan
-
Investigational Site Number : 3920002
Chūō, Tokyo, 103-0025, Japan
-
Investigational Site Number : 3920003
Shinjuku-ku, Tokyo, 169-0072, Japan
-
Investigational Site Number : 3920004
Taitō City, Tokyo, 111-0036, Japan
Conditions
Explore the condition pages connected to this study.